2.07 USD
-0.05
2.36%
At close Apr 21, 4:00 PM EDT
Pre-market
2.06
-0.01
0.48%
1 day
-2.36%
5 days
-14.46%
1 month
-22.47%
3 months
-51.97%
6 months
-39.47%
Year to date
-51.75%
1 year
-41.03%
5 years
-79.90%
10 years
-79.90%
 

About: DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Employees: 4,407

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

33% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]

30% more capital invested

Capital invested by funds: $181M [Q3] → $234M (+$53.9M) [Q4]

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 126 [Q3] → 128 (+2) [Q4]

0.98% more ownership

Funds ownership: 53.11% [Q3] → 54.1% (+0.98%) [Q4]

29% less call options, than puts

Call options by funds: $194K | Put options by funds: $273K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4
93%
upside
Avg. target
$4.75
129%
upside
High target
$5.50
166%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Needham
Ryan MacDonald
32% 1-year accuracy
26 / 81 met price target
93%upside
$4
Buy
Reiterated
8 Apr 2025
Stifel
David Grossman
38% 1-year accuracy
6 / 16 met price target
166%upside
$5.50
Buy
Maintained
28 Feb 2025

Financial journalist opinion

Based on 5 articles about DCGO published over the past 30 days

Neutral
Business Wire
1 day ago
DocGo to Announce First Quarter Results on Thursday, May 8, 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (.
DocGo to Announce First Quarter Results on Thursday, May 8, 2025
Neutral
PRNewsWire
3 days ago
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
NEW YORK and NEW ORLEANS , April 18, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
Neutral
Business Wire
2 weeks ago
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into DocGo Inc. (NasdaqCM: DCGO). DocGo is a healthcare company that provides medical transportation and mobile health services in the United States and the United Kingdom. In September 2023, news media sources reported numerous alleged misrepresentations by the Company, includin.
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
Neutral
Business Wire
3 weeks ago
DocGo Earns Great Place To Work Certification™ For the Third Time in a Row
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that it has been Certified™ by Great Place To Work® for the third time in a row. This prestigious award is based on what current employees say about their experience working at the Company. This year, employees rated DocGo 31% higher than the average US company as a Great Place to Work. Great Place To Work® is the global authority on w.
DocGo Earns Great Place To Work Certification™ For the Third Time in a Row
Neutral
Business Wire
4 weeks ago
DocGo Announces Upcoming Participation at Needham Virtual Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Needham Virtual Healthcare Conference on Monday, April 7th at 11:45 AM Eastern Time, and hold virtual 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is l.
DocGo Announces Upcoming Participation at Needham Virtual Healthcare Conference
Positive
Seeking Alpha
1 month ago
DocGo: I'm Still On The Fence On This One
DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contracts for a significant part of its revenues, much of which has now dried up. The company is transitioning to a new revenue model targeting Health Insurance Partnerships, aiming for more stable and predictable revenues. Yet, this space is highly competitive.
DocGo: I'm Still On The Fence On This One
Positive
Zacks Investment Research
1 month ago
All You Need to Know About Motion Acquisition (DCGO) Rating Upgrade to Buy
Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Motion Acquisition (DCGO) Rating Upgrade to Buy
Neutral
Seeking Alpha
1 month ago
DocGo, Inc (DCGO) Q4 2024 Earnings Call Transcript
DocGo, Inc (NASDAQ:DCGO ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity David Larsen - BTIG Aidan Conniff - Stifel Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2024 Earnings Call. At this time, all lines are in listen only mode.
DocGo, Inc (DCGO) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
DocGo Inc. (DCGO) Q4 Earnings Beat Estimates
DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago.
DocGo Inc. (DCGO) Q4 Earnings Beat Estimates
Neutral
Business Wire
1 month ago
DocGo Announces Fourth Quarter and Full-Year 2024 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter and full-year ended December 31, 2024. Full-Year 2024 Financial Highlights Full-year 2024 revenue was $616.6 million, compared to $624.2 million for the full-year 2023. GAAP gross margin (which includes non-cash depreciation expenses) for the full-year 2024 was 32.1%, compared to 28.7% fo.
DocGo Announces Fourth Quarter and Full-Year 2024 Results
Charts implemented using Lightweight Charts™